Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

New York, Jan 9, 2026, 14:28 EST — Regular session Shares of Nasdaq-listed HealthEquity (HQY) fell 2.9% to $95.64 in afternoon trade on Friday after Goldman Sachs cut its rating to sell from neutral and set an $89 price target. The stock hit a session low of $92.97 before it pared some of the drop. (GuruFocus) The downgrade lands at a touchy moment for the name: the Goldman analyst argued 2026 may bring a “return to normalized patterns” where organic growth — growth without acquisitions — drives how investors price the stock. He also warned the valuation multiple, the price
9 January 2026
·····
Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

New York, Jan 9, 2026, 14:36 (EST) — Regular session Nuvation Bio Inc (NUVB) shares slid about 4.7% to $8.05 Friday afternoon, after earlier hitting a session low of $8.05. The stock’s pullback follows new sell-side takes on a name that’s been re-rated since shifting into the commercial stage. UBS started coverage at Neutral with a $10 price target. RBC, meanwhile, lifted its target to $9 from $8 and maintained an Outperform rating, calling the stock “speculative risk.” (MarketScreener) UBS analyst Michael Yee said the bigger picture is starting to turn, arguing biotech “fundamentals are now inflecting” as investor confidence
9 January 2026
···
Strategy Inc (MSTR) stock slides 5% as Clear Street cuts target; MSCI decision nears

Strategy Inc (MSTR) stock slides 5% as Clear Street cuts target; MSCI decision nears

NEW YORK, Jan 9, 2026, 14:32 EST — Regular session Strategy Inc shares slid about 5% Friday afternoon, underperforming a rising market after an analyst cut a price target on the bitcoin-linked software company. The stock fell $8.52 to $158.45. Bitcoin eased 0.9% to about $90,217, while the Nasdaq-tracking QQQ ETF was up about 1.1%. Strategy’s stock can swing wildly because the company has hitched its balance sheet to bitcoin. Strategy, formerly MicroStrategy, calls itself a bitcoin treasury company — it holds bitcoin as its primary treasury reserve asset and has financed purchases through capital markets alongside its software business.
9 January 2026
·····
DoorDash stock slides nearly 4% as Feb. 18 earnings date nears and CEO sale shows up in filings

DoorDash stock slides nearly 4% as Feb. 18 earnings date nears and CEO sale shows up in filings

New York, January 9, 2026, 14:34 EST — Regular session DoorDash (DASH.O) shares were down about 3.8% at $215.66 in afternoon trade on Friday, after earlier touching $224.80. The stock was $8.44 below its previous close. The retreat comes as investors turn to DoorDash’s next results for clues on how fast spending is rising in 2026 and whether growth is cooling. DoorDash, Inc. said on Wednesday it will release fourth-quarter and full-year 2025 results after U.S. markets close on Feb. 18. (ir.doordash.com) A conference call will follow at 5 p.m. ET. Traders expect management to spend much of the time
9 January 2026
·····
PVH stock slips as Supreme Court tariff decision hangs over retailers — what traders watch next

PVH stock slips as Supreme Court tariff decision hangs over retailers — what traders watch next

New York, Jan 9, 2026, 14:33 EST — Regular session PVH Corp shares fell 4.4% to $65.32 on Friday afternoon, extending a choppy week for the Calvin Klein and Tommy Hilfiger owner. The drop comes as investors wait on U.S. tariff policy, after the Supreme Court said it would not rule on the legality of President Donald Trump’s sweeping tariffs on Friday and is expected to issue its next decisions on Jan. 14. (Reuters) That matters for import-heavy brands because tariff outcomes can swing costs quickly, while the broader market was leaning risk-on after a softer December U.S. jobs report
9 January 2026
···
MakeMyTrip stock slides 4.5% in U.S. trade as investors turn to Jan. 22 earnings

MakeMyTrip stock slides 4.5% in U.S. trade as investors turn to Jan. 22 earnings

New York, Jan 9, 2026, 14:10 EST — Regular session MakeMyTrip Limited (MMYT.O) shares fell 4.5% to $78.78 in afternoon trading on Friday, after touching an intraday high of $83.42 and then sliding to as low as $78.37. The stock opened at $82.64 and had traded about 577,000 shares by mid-session. The drop puts the stock on course for its weakest close since early January and comes with MakeMyTrip heading into its next quarterly update later this month. Nasdaq’s market activity page lists an earnings date of Jan. 22, though the company has not posted a fresh press release on
9 January 2026
····
Lululemon stock sinks nearly 5% as Supreme Court tariff ruling slips, keeping retailers on edge

Lululemon stock sinks nearly 5% as Supreme Court tariff ruling slips, keeping retailers on edge

New York, January 9, 2026, 13:57 EST — Regular session lululemon athletica inc shares dropped 4.9% to $201.88 on Friday and sank to a session low of $201.40 in afternoon trade, after the U.S. Supreme Court said it would not issue an expected ruling on the legality of President Donald Trump’s sweeping tariffs. (Reuters) The delay is important because the case has turned into a live macro trade for import-heavy companies, with investors scanning for any hint of relief from duties that have squeezed margins. Any rollback could also set off a round of refunds to importers, and BNY Markets’
9 January 2026
······
WD-40 stock slides 6% after Q1 profit falls; guidance held and Asia rebound in focus

WD-40 stock slides 6% after Q1 profit falls; guidance held and Asia rebound in focus

NEW YORK, January 9, 2026, 14:00 ET — Regular session WD-40 Company shares fell 5.6% to $192.13 on Friday afternoon, after the lubricant maker posted a drop in first-quarter profit and higher expenses. The stock was down as much as nearly 14% earlier in the session. The move matters because WD-40 tends to trade like a steady compounder. When profit slips, the market usually asks if it’s just timing — or something that sticks. Management put the soft patch on distributor markets, where the company sells through third-party partners, and said direct markets kept growing. Investors are now looking for
9 January 2026
····
Atour Lifestyle (ATAT) stock slides about 4% in U.S. trade as rate bets shift, CPI looms

Atour Lifestyle (ATAT) stock slides about 4% in U.S. trade as rate bets shift, CPI looms

NEW YORK, Jan 9, 2026, 13:24 EST — Regular session Atour Lifestyle Holdings’ U.S.-listed shares slid 4.2% to $40.20 in early afternoon trading on Friday, after moving between $39.85 and $42.02. Trading volume was about 894,000 shares. The decline comes as Wall Street digests fresh U.S. data that nudged rate-cut odds lower, while investors also track the legal fight over President Donald Trump’s tariffs. “Payrolls were a little bit light relative to consensus, but still fairly strong numbers,” Tim Ghriskey, a senior portfolio strategist at Ingalls & Snyder, said. (Reuters) The Labor Department reported nonfarm payrolls rose by 50,000 jobs
9 January 2026
·······
Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

NEW YORK, Jan 9, 2026, 14:11 EST — Regular session Kohl’s Corp (KSS) shares were off roughly 5.1% at $20.66 Friday afternoon, after a choppy session that ran from $22.27 down to $20.43. The department-store operator opened at $22.00. The stock trailed even as the broader market found its footing after a softer U.S. jobs report. The U.S. Supreme Court said it would not issue a ruling on Friday on the legality of President Donald Trump’s sweeping tariffs, leaving investors still waiting on clarity around duties that can shift costs for import-heavy retailers. (Reuters) Importers and trade lawyers are girding
9 January 2026
····
Star Bulk Carriers (SBLK) stock drops nearly 5% as dry-bulk freight gauge slips

Star Bulk Carriers (SBLK) stock drops nearly 5% as dry-bulk freight gauge slips

NEW YORK, January 9, 2026, 13:43 EST — Regular session Star Bulk Carriers Corp shares fell 4.8% to $19.76 by 1:25 p.m. EST on Friday, after earlier touching $20.75. The stock’s 52-week range runs from $12.06 to $20.87, and the company’s market value stood near $2.4 billion. (Star Bulk Carriers) The drop landed as the Baltic Dry Index — a widely watched gauge of what it costs to ship dry bulk cargoes like iron ore, coal and grain — eased to 1,688 on Friday and has fallen about 31% over the past month. (Trading Economics) That matters right now because
9 January 2026
·····
Establishment Labs stock slides 5%: traders eye Motiva FDA next steps and JPM conference talk

Establishment Labs stock slides 5%: traders eye Motiva FDA next steps and JPM conference talk

New York, Jan 9, 2026, 13:50 EST — Regular session Establishment Labs Holdings Inc. shares slid about 5% to $69.22 in early afternoon trading Friday, after earlier rising as high as $74.37. The move stands out because the stock has been among the sharper movers in small-cap medical devices this week, and traders are balancing two timelines: near-term investor events and the longer U.S. regulatory process for its Motiva breast implants. On Friday, the broader market climbed after U.S. data showed employers added 50,000 jobs in December, leaving rate-cut bets intact even as the unemployment rate ticked down to 4.4%.
9 January 2026
···
1 … 357 358 359 360 361 … 884

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop